GE HealthCare Technologies Inc. Former Officer Files Form 144 for $6.73M Sale

Overview

On November 4, 2026, James Saccaro, identified as a Former Officer of GE HealthCare Technologies Inc. (CIK: 0001932393), filed a Form 144 notice disclosing the intended sale of 78,348 shares of Common Stock through UBS Financial Services Inc. The estimated aggregate market value of the proposed transaction is $6,731,613.46, representing an implied share price of approximately $85.92.

Transaction Details

• Securities to be Sold: 78,348 shares of Common Stock.
• Origin of Shares: Acquired on November 4, 2026, via two stock option exercises (54,472 shares and 23,876 shares) directly from GE HealthCare Technologies Inc.
• Market Impact: The 78,348 shares represent approximately 0.017% of the company's 452,137,831 total shares outstanding.

Significance

The trading significance is rated as Medium. While the aggregate dollar amount ($6.73M) is substantial, the shares were generated through immediate option exercises and the filer is a former officer. Dispositions by former insiders typically reflect personal liquidity, post-employment option expiration management, or portfolio diversification rather than an informational signal regarding operational performance.